Document Detail


Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas.
MedLine Citation:
PMID:  10590069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Primary effusion lymphomas (PELs), which are rare lymphomas associated with Kaposi's sarcoma-associated herpesvirus (or human herpesvirus-8) infection, present as malignant lymphomatous effusions in body cavities. Because PELs prefer liquid growth, we hypothesized that increased vascular permeability would be required for effusions to form. We found that the PEL cell lines BC-1, BCP-1, and BCBL-1 produce high levels of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF). Reverse transcriptase-polymerase chain reaction analysis of RNA from the PEL cell lines amplified the 3 VEGF-secreted isoforms: VEGF/VPF(121), VEGF/VPF(145), and VEGF/VPF(165). Two of the PEL cell lines expressed the VEGF/VPF receptor Flt-1, but VEGF/VPF did not stimulate proliferation in these cells. Most (13/14) control SCID/beige mice inoculated intraperitoneally with BCBL-1 cells and subsequently observed or treated with control antibodies developed effusion lymphoma of human cell origin with prominent bloody ascites. In contrast, none (0/9) of the mice treated with a neutralizing antihuman VEGF/VPF antibody developed ascites and effusion lymphoma. These results demonstrate that VEGF/VPF is critical to BCBL-1 growth as effusion lymphoma in mice and suggest that VEGF/VPF stimulation of vascular permeability may be critical to the pathogenesis of PELs.
Authors:
Y Aoki; G Tosato
Related Documents :
17201239 - Expression of vascular endothelial growth factor and hypoxia-inducible factor in the ai...
7683699 - Patterns of expression of vascular endothelial growth factor (vegf) and vegf receptors ...
10741909 - Expression of vascular endothelial growth factor in surgical specimens of hepatocellula...
10657259 - Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 an...
12794819 - Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor...
20036889 - Expression of vegf, vegf-c and vegfr-2 in in situ and invasive scc of cervix.
22294119 - Measurement of vla-4/cs-1 and vla-4/vcam adhesion inhibition.
12652029 - Tensile adhesion of type i collagen to titanium alloy and calcium phosphate coated surf...
16920299 - Cml-1 inhibits tnf-alpha-induced nf-kappab activation and adhesion molecule expression ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood     Volume:  94     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-10     Completed Date:  2000-01-10     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  4247-54     Citation Subset:  AIM; IM; X    
Affiliation:
Division of Hematologic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. AOKI@CEBR.FDA.GOV
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Capillary Permeability
Cell Division
Endothelial Growth Factors / physiology*
Herpesvirus 8, Human*
Humans
Lymphokines / physiology*
Lymphoma, Non-Hodgkin / pathology,  physiopathology*,  virology*
Mice
Proto-Oncogene Proteins / physiology
Receptor Protein-Tyrosine Kinases / physiology
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factors
Chemical
Reg. No./Substance:
0/Endothelial Growth Factors; 0/Lymphokines; 0/Proto-Oncogene Proteins; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; EC 2.7.10.1/Receptor Protein-Tyrosine Kinases; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
Next Document:  c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression.